Abstract
Pyrrolo[1,2-b]pyridazin-2-one analogs were discovered as a novel class of inhibitors of genotype 1 HCV NS5B polymerase. Structure-based design led to the discovery of compound 3 k, which displayed potent inhibitory activities in biochemical and replicon assays (IC(50) (1b)<10nM; EC(50) (1b)=12 nM) as well as good stability towards human liver microsomes (HLM t(1/2)>60 min).
MeSH terms
-
Animals
-
Antiviral Agents / chemical synthesis
-
Antiviral Agents / chemistry
-
Antiviral Agents / pharmacology*
-
Binding Sites / drug effects
-
Cell Line
-
Crystallography, X-Ray
-
Humans
-
Hydrogen Bonding
-
Microbial Sensitivity Tests
-
Models, Molecular
-
Molecular Structure
-
Pyridazines / chemical synthesis
-
Pyridazines / chemistry
-
Pyridazines / pharmacology*
-
Pyrroles / chemical synthesis
-
Pyrroles / chemistry
-
Pyrroles / pharmacology*
-
Structure-Activity Relationship
-
Viral Nonstructural Proteins / antagonists & inhibitors*
-
Viral Nonstructural Proteins / chemistry
Substances
-
Antiviral Agents
-
Pyridazines
-
Pyrroles
-
Viral Nonstructural Proteins
-
NS-5 protein, hepatitis C virus